H

Helocyte, Inc.

2 employees

Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Pharmaceutical
Therapeutics
Health Care

Date founded

2015

Funding rounds raised

Total raised

$4M

from 2 investors over 2 rounds

H

Helocyte, Inc. raised $3.2M on June 15, 2023

Investors: National Cancer Institute

H

Helocyte, Inc. raised $4M on October 1, 2016

Investors: SternAegis Ventures

FAQ